No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪95.67 B‬INR
‪1.43 B‬INR
‪11.48 B‬INR
‪25.78 M‬
Beta (1Y)


Surendran Chemmenkotil
Employees (FY)
‪4.77 K‬
Metropolis Healthcare Ltd. owns and operates medical laboratories. The firm operates through Pathology Services. It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry. The company was founded by Sushil Kanubhai Shah and Gomathi Babu Sadacharam Kulandai Velu in 1981 and is headquartered in Mumbai, India.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of METROPOLIS is 1840.60 INR — it has increased by 0.13% in the past 24 hours. Watch METROPOLIS HEALTHC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange METROPOLIS HEALTHC stocks are traded under the ticker METROPOLIS.
METROPOLIS stock has risen by 6.27% compared to the previous week, the month change is a 5.48% rise, over the last year METROPOLIS HEALTHC has showed a 47.10% increase.
We've gathered analysts' opinions on METROPOLIS HEALTHC future price: according to them, METROPOLIS price has a max estimate of 2010.00 INR and a min estimate of 1234.00 INR. Watch METROPOLIS chart and read a more detailed METROPOLIS HEALTHC stock forecast: see what analysts think of METROPOLIS HEALTHC and suggest that you do with its stocks.
METROPOLIS reached its all-time high on Dec 30, 2021 with the price of 3579.90 INR, and its all-time low was 907.00 INR and was reached on May 13, 2019. View more price dynamics on METROPOLIS chart.
See other stocks reaching their highest and lowest prices.
METROPOLIS stock is 1.50% volatile and has beta coefficient of 1.21. Track METROPOLIS HEALTHC stock price on the chart and check out the list of the most volatile stocks — is METROPOLIS HEALTHC there?
Today METROPOLIS HEALTHC has the market capitalization of ‪94.39 B‬, it has decreased by 0.07% over the last week.
Yes, you can track METROPOLIS HEALTHC financials in yearly and quarterly reports right on TradingView.
METROPOLIS HEALTHC is going to release the next earnings report on May 21, 2024. Keep track of upcoming events with our Earnings Calendar.
METROPOLIS earnings for the last quarter are 5.30 INR per share, whereas the estimation was 6.87 INR resulting in a −22.88% surprise. The estimated earnings for the next quarter are 7.44 INR per share. See more details about METROPOLIS HEALTHC earnings.
METROPOLIS HEALTHC revenue for the last quarter amounts to ‪2.91 B‬ INR despite the estimated figure of ‪2.95 B‬ INR. In the next quarter revenue is expected to reach ‪3.08 B‬ INR.
METROPOLIS net income for the last quarter is ‪271.58 M‬ INR, while the quarter before that showed ‪354.55 M‬ INR of net income which accounts for −23.40% change. Track more METROPOLIS HEALTHC financial stats to get the full picture.
METROPOLIS HEALTHC dividend yield was 0.64% in 2022, and payout ratio reached 28.66%. The year before the numbers were 0.39% and 19.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 18, 2024, the company has ‪4.77 K‬ employees. See our rating of the largest employees — is METROPOLIS HEALTHC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. METROPOLIS HEALTHC EBITDA is ‪2.73 B‬ INR, and current EBITDA margin is 26.40%. See more stats in METROPOLIS HEALTHC financial statements.
Like other stocks, METROPOLIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade METROPOLIS HEALTHC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So METROPOLIS HEALTHC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating METROPOLIS HEALTHC stock shows the buy signal. See more of METROPOLIS HEALTHC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.